BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

DELMAR PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

DELMAR PHARMACEUTICALS

via U.S. GOVERNMENT RELATIONS INTL.

3rd Quarter (July 1 - Sep 30) · 2017Posted Nov 7, 2017Filing document ↗LDA record ↗

Income$7Kfee reported

Client

Name: DELMAR PHARMACEUTICALS
Description: Cancer research company GBM and Ovarian cancers
Location: California · United States of America

Registrant

Firm: U.S. GOVERNMENT RELATIONS INTL.
Description: U.S. government relations
Location: Falls Church, Virginia, United States of America

Lobbying activities

1 issue

Pharmacy
Educate Congress on matters involving cancer research specifically GBM and ovarian cancers
LobbyistsJEFFREY L TAYLOR
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.